Member Info for potnak

At the risk of trolling the board and unleashing the "you have an agenda trope". I guess what you are saying is RF aren't very good at backing winners?

I admire your attitude to risk, Krusty. Whilst I'm not confident of a life changing rerate, I think you could well make a very nice profit, if you chose to trade some on news.

37p was my old average, 0.74p. 0.18p was the lowest point I ever bought in. Technically, I'm in profit because I took my initial stake out several times. Still stings though. With the RF drawdown due anytime, the 20's could be breached very soon.

I did think that when I wrote it. Seriously though, if they do miss the deadline this time. Questions need to be asked.

There isn't anything the board can do. Good or bad, What has been done, is already done. Its interesting you used the word disciples in an earlier post. the scales are tipping into the negative sentiment and every ardent long-termer will have a breaking point where they think, "well, this is a bit sh@t"

We need data and we are not that far away from the first tranche of data. April\May possibly before or they won't meet their own deadline of P1b completion this year.

I don't think we can force anyone's hand, Ben. It is my opinion that the last RNS we got was an honest update, clearly stating the plan and timescales. The damage, if you can call it that, has been done. We are stuck with RF until they are paid back. I think Damion's points re P1a trials are as good as we will get and if true, mean we don't have long to wait until we get news from 1a, good or bad. Personally, I don't think we will get a deal until 1b data is in. If the board are truthful, then we should be funded up to the end of 1b. I know some think we will get a deal on 1a data and I'm in no position to disagree with that. My concern with that is with an early license, the upfront will be small, maybe enough to keep the lights on and fund 1802 in P1 but no real shareholder value.

Either way, I think, once spring arrives, we will be stuck around the £1 level until 737 news or rumors about P1b leak.

I reckon a 5 million share dillution, if not more by the time the facility is settled. My main gripe is they knew this point was coming. They always knew it was coming. Imagine if they had offered 5 million shares at a discount when we were sitting comfortably over £2. We'd have enough cash to see us through phase 2. Don't anyone say 'hindsight' a few if us were saying it at the time. Including the late Thoth.

I reckon I will buy 1 more tranche this month. Then that's me done. Hibernate until news.

One thing I won't miss, is the God awful gui on this site. Last post was littered with auto spell but I could couldn't go back and edit as only the page would scroll, not the text.

Aber, I feel for you. I know you have a large holding, and I know you must have watched a £1 million pound profit just disappear but it is what it is. You have to accept that without news the sp will stop into the 30's possibly the 20's, even. It's sh@t and there isn't a great deal we can do about it. I have been asking at what price even the most bills shareholder will start to question what us going on. We're getting there and I fear we will fall loser that most here ever imagined.

Bad news is the next tranche of funding is imminent, this or next week. Personally, I rather they take the whole lot now, £1.7 million, I think it is. Use that to kick start any work needed on translational studies for 1802. If we are going to zero may as well go disn with a fight

The good news is we aren't that far from a pivotal data releases for 1a. That should stabilise the SP for a bit but while ever RF are around, we are hamstrung until an early deal or 1b data. I'll be OK with that if 1a safety is good.

Simple, we keeping living them more shares until our debt is cleared. As long as the company does OK, They can't lose in that respect.

Warthog. I've been vocal that I hold the board responsible for the situation we're in. I'm not going to list the reasons why and I'm not interested in hearing weak defenses, such as having faith, believing, or trusting the science. But to answer your question, I'd wager that unless people need the cash, they will let it run, even if it does 5 bag from here. I suspect you will too. I am, however, buying in small amounts and will keep buying down to 37p. I have added approx 7000 shares since RF came onboard and I will sell these on any spike, leaving my main pot invested. Averaging down is never a good strategy but for those deep underwater, it could get your money back back quicker. Of course, you could be throwing good money after bad too.

Yes, Luton! Manipulation of the share price to make a profit is the job description for an MM. They walk the SP down in quiet times because that's the easiest way to generate trades. The RF finance facility is making their job very easy at the minute. I'm bullish in the short term, mainly because, unless there is a catastrophe, we look like passing p1a. Safety assured is a big deal. It might not be enough to get us a licence but it should attract new investors. I'm in agreement with Damion. March/April for news. This is why I'm buying.

Sareum have already used PYC's computational models. We are passed where it would even be relevant though. Unless we aquire the rights to a new compound.

I sort of agree, Andy but that scenario only works if we are following all the way to market. There is plenty of time to do a deal that will add significant value way before we get to find if it is the drug we've been waiting for. I certainly down want to go past phase 2 and will look for exits all the way yo that point.

Who said anything about del boy? I'm talking Peel Hunt or some other big org that can open the doors for us. And Laz, I know you know the score, you know we need data, you know what a deal is likley to do to the SP. Not sure who made the squeaky chair comment. It's funny but also true. Tim Mitchells job as CEO, is to generate shareholder value. They've taken the cash from the market, his job, to the best of his ability, is to pay that cash back. Imagine negotiating a deal worth 100's of millions, if not billions and um'ing & ar'ing with punctuation from a squeaky chair all the way through the presentation. I'm jot saying we need a guy in a shiny suit but we do need someone who can talk with authority and confidence about the compounds. That may be TM and Parker but I'm not convinced yet.

Ha ha, celtic. You're like the spotty little kid who follows the school prefect around. Agreeing with everything they say. This is said in jest BTW.

I'm past the rose tinted view of the science will save us. It's like any other investment, whether that be tech, oil, miners etc. I've said this a few times, not all AIM companies that fail have a failed product. They mostly fail because of lack of fiance, bad management or just fizzle out. A good deal maker could get us a deal way before the compound fails or proves itself. We've done the science, it's now time to pursue the shareholder value.

Yes, Aber. The trust the science things always triggers me. We need Mitchell and Parker to be deal makers and if they need help in brokering a deal they should seek it but I guess this is where Peel Hunt will come in. However, the sp is looking very cheap, with a potential upside on 1a data. Possibly back over a pound and back in institutional investor range. I'm not sure we'll get a deal before 1b data, mainly because the RNS's usually states that as the plan. But 1a data, a big regulatory hurdle cleared, could be as close as end of March. Not long to wait.

Some good points in Damion's assessment, getting lost in the usual bickering. All this fits in with the RNS saying first half of 2024. it a gamble but still an buying opportunity for me.

Feels like something SAR should at least tweet.